Atlas Trials

Liposomal Bupivacaine Single-Injection Interscalene Block vs. Continuous Interscalene Block for Primary Total Shoulder Arthroplasty

Clinical trial NCT05005260 · COMPLETED

Trial details

NCT number
NCT05005260
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pain, PostoperativeBrachial Plexus Block
Start date
2021-10-14
Primary completion
2023-03-18
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.